Lv4
440 积分 2026-04-24 加入
Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease
8天前
已完结
Kawakinra: A phase IIA multicenter trial to assess the efficacy, and safety of anakinra in patients with intravenous immunoglobulinresistant Kawasaki disease
8天前
已完结
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease
9天前
已完结
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
10天前
已完结
Safety and Feasibility of InfliximabTherapy in Children with Kawasaki Disease Who Received Live Vaccinations
22天前
已关闭
Third-line therapies in patients with Kawasaki disease refractory to first- and second-line intravenous immunoglobulin therapy
22天前
已完结
Etanercept with IVIg for acute Kawasaki disease: a long-term follow-up on the EATAK trial
22天前
已完结
A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis
1个月前
已完结
One year in review:Kawasaki disease
1个月前
已完结
皖公网安备34019202002308
